27 filings · most recent first
MRNA 8-K Filings
Moderna Reports Q2 2026 Financial Results And Pipeline Updates
Moderna Appoints Michael Mcdonnell To Board Of Directors
Moderna Updates Bylaws And Announces Annual Meeting Results
Moderna Reports First Quarter 2026 Financial Results And Business Updates
Moderna Settles Patent Infringement Litigation With Arbutusgenevant
Moderna Reports Fourth Quarter 2025 Financial Results And Business Updates
Modernas Bla For Seasonal Influenza Vaccine Mrna1010 Refused By Fda
Moderna Updates 2025 Financial Performance And 2026 Outlook
Moderna Reports 2025 Performance And Outlines 2026 Outlook
Moderna Inc Announces Third Quarter 2025 Financial Results
Moderna Reports Second Quarter 2025 Financial Results And Business Updates
Moderna Stockholders Approve Key Proposals At 2025 Annual Meeting
Moderna Reports First Quarter 2025 Financial Results And Business Updates
Moderna Reports 2024 Financial Results And Provides 2025 Outlook
Moderna Reports Preliminary 2024 Financial Results And Provides 2025 Outlook
Moderna Reports Q3 2024 Financial Results And Business Updates
Moderna Appoints Abbas Hussain To Board Of Directors
Moderna Announces Rd Updates And Financial Framework Extension
Moderna Reports Second Quarter 2024 Financial Results And Business Updates
Moderna Announces Board Changes With Appointment Of David Rubenstein And
Moderna Inc Approves Major Corporate Governance Amendments At Annual Meeting
Moderna Reports Q1 2024 Financial Results And Business Updates
Moderna Announces Fourth Quarter And Full Year 2023 Financial Results
Moderna Reports 2023 Financial Results And Provides Business Update
Moderna Inc Announces New 15 Billion Credit Facility
Moderna Discloses Pipeline Progress And Business Strategy Updates
Moderna Approves Onetime Stock Option Exchange Program